Table 1 Effectiveness Outcomes, Measures, Target Population, Timing and Analysis
Variable/Outcome | Measure | Study Group(s)a | Timingb | Method of Analysis |
|---|---|---|---|---|
Mental functioning | Mental component summary (MCS) from SF-12 [64] | CT, CG | T1, T2 | Descriptive analyses T1-T2 (Treatment Effect); ANCOVA, subgroup analyses (sex, number of chronic conditions, province) |
Physical functioning | Physical Component Summary (PCS) from SF-12 [64] | CT, CG | T1, T2 | Descriptive analyses T1-T2 (Treatment Effect); ANCOVA |
Diabetes self care | Summary of Diabetes Self Care Activities (SDSCA) [65] | CT | T1, T2 | Descriptive analyses T1-T2 (Treatment Effect); ANCOVA |
Depressive symptoms | Center for Epidemiological Studies Depression Scale (CES-D-10) [66] | CT, CG | T1, T2 | Descriptive analyses T1-T2 (Treatment Effect); ANCOVA |
Anxiety | Generalized Anxiety Disorder 7-item Scale (GAD-7) [67] | CT, CG | T1, T2 | Descriptive analyses T1-T2 (Treatment Effect); ANCOVA |
Social support | Duke Social Support Index (DSSI) [68] | CT | T1, T2 | Descriptive analyses T1-T2 (Treatment Effect); ANCOVA |
Physical activity | Physical Activity Scale for the Elderly (PASE) [69] | CT | T1, T2 | Descriptive analyses T1-T2 (Treatment Effect); ANCOVA |
Activities of daily living/instrumental activities of daily living | Older Americans Resources and Services Multidimensional Functional Assessment Questionnaire Activities of Daily Living/Instrumental Activities of Daily Living (OARS ADL/IADL) [70, 71] | CT | T1, T2 | Descriptive analyses T1-T2 (Treatment Effect); ANCOVA |
Eating and nutrition risks | Seniors in the Community: Risk Evaluation for Eating and Nutrition (SCREEN II-AB) [72] | CT | T1, T2 | Descriptive analyses T1-T2 (Treatment Effect); ANCOVA |
Food security | Single item from Canadian Longitudinal Study on Aging [73] | CT | T1, T2 | Descriptive analyses |
Diabetes-related complications | Self-report of retinopathy, neuropathy, peripheral vascular disease | CT | T1, T2 | Descriptive analyses |
Laboratory values | HbA1c, e-GFR, LDL cholesterol | CT | T1, T2 | Descriptive analyses, Inferential statistical analysis of T1-T2 change |
Caregiver strain | Modified Caregiver Strain Index (CSI) ā 13 items [74] | CG | T1, T2 | Descriptive analyses T1-T2 (Treatment Effect); ANCOVA |
Utilization of health and social services and associated costs | Health and Social Services Utilization Inventory (HSSUI) [75, 76] | CT, CG | T1, T2 | Descriptive analyses T1-T2 (treatment Effect); Parametric or non-parametric tests depending on distributional properties of cost data, complete case analysis, Hazard Ratio (95% CI) & Risk Difference (95% CI) for ED visits and hospital admissions |
Interprofessional team functioning | Partnership Self-Assessment Tool (PSAT) [77] | INT | 3 months and end of intervention | Descriptive analyses |
Public and community partner engagement | The Quality Involvement Measure [78] The Patient-Centred Outcomes Research Instituteās Ways of Engaging ā Engagement Activity (WE-ENACT) Tool [79] Selected items of the Patient-Centred Outcomes Research Instituteās Engagement Activity Inventory (NET-ENACT) Tool [80] | Public and community research partners | 3 months and end of intervention | Descriptive analyses |